サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1362865

ヒト成長ホルモンの市場規模、シェア、動向分析レポート：流通チャネル別、用途別、製品別、地域別、セグメント予測、2023年～2030年

Human Growth Hormone Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Application, By Product, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 129 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ヒト成長ホルモンの市場規模、シェア、動向分析レポート：流通チャネル別、用途別、製品別、地域別、セグメント予測、2023年～2030年
出版日: 2023年09月01日
発行: Grand View Research
ページ情報: 英文 129 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヒト成長ホルモン市場の成長と動向

Grand View Research, Inc.の最新レポートによると、ヒト成長ホルモンの世界市場規模は、2023年から2030年にかけて12.3%のCAGRで成長し、2030年には142億8,000万米ドルに達する見込みです。

同市場は、成長ホルモン欠乏症やその他の成長関連疾患の罹患率の増加により成長を目の当たりにしています。また、革新的で費用対効果の高い治療オプションの開発に努める主要企業間の熾烈な競争が市場成長の原動力となっています。子供の成長に関する親の関心の高まりが、ヒト成長ホルモン（HGH）療法に対する需要の高まりに寄与しています。カナダ・トゥデイのレポートでは、親が子供の身長に特別な関心を示し、小人症の治療オプションに投資する意欲を示していることが強調されています。

同様に中国では、医学的な異常がない場合でも、小児に対するHGH治療の需要が高いです。子どもの正常な発育に対するこうした懸念の高まりは、業界関係者に新たな機会をもたらしています。北米は、国民のヘルスケア意識の高まり、政府の重要なイニシアティブ、同地域の有利な償還政策に牽引され、急速な成長を遂げると予測されています。さらに、研究開発活動の活発化、十分な研究資金の確保、認知度向上と治療法の選択肢を積極的に推進する組織の存在が、この地域の市場成長を促進すると予想されます。

さらに、北米市場はファイザー社やリリー社をはじめとする主要企業の存在が大きく、世界市場における収益性の高い収益シェアに大きく貢献しています。規制当局の承認数の増加や革新的なHGH治療レジメンの導入も市場拡大に寄与しています。例えば、2022年1月、Pfizer, Inc.とOPKO Health, Inc.は、米国食品医薬品局（FDA）から、成長ホルモン欠乏症治療のための週1回投与の先進的な長時間作用型成長ホルモン注射剤であるNGENLAの市販承認を取得しました。NGENLAは、米国では2023年8月から処方可能となる予定です。

同様に、2021年8月、米国FDAは、アセンジス・ファーマ社が発売したロナペグソマトロピン-tcgd（SKYTROFA）を、小児患者の発育停止治療薬として承認しました。こうした規制当局の承認と新規HGHレジメンの発売が市場の拡大に寄与し、この分野のさらなる進歩を促進しています。北米は、早期診断の重視とともに、成長ホルモン欠乏症とその治療法に関する人々の意識の高まりにより、2022年に最大の売上シェアを占めました。アジア太平洋地域は、大手企業による投資の増加やジェネリック医薬品の採用急増により、予測期間中に最も速いCAGRを示すと予想されます。

インドと中国は、人口の多さを背景に、ヘルスケア分野の発展に大きな機会を提供すると予想されます。そのため、HGH医薬品を専門とする企業を含む製薬企業は、これらの国々で多額の投資を行っています。ファイザー社、ノバルティス社、メルク社、テバ・ファーマシューティカル・インダストリーズ社が世界市場を独占しています。これらの企業は、市場シェアを拡大するために、新製品開発、M&A、提携などの戦略を採用しています。2023年6月、世界の健康・フィットネス業界のリーダーであるドメスティック・サプライ社は、科学的に検証されたHGHサプリメントを発売しました。この斬新な製品は、パフォーマンス向上と総合的な健康の分野で目覚ましい進歩を遂げ、世界中の健康志向の人々に生活の質の向上を提供しています。

ヒト成長ホルモン市場レポートハイライト

  • 製品別では、短時間作用型成長ホルモンを含むその他セグメントが2022年の市場を独占。短時間作用型GH療法に対する規制当局による承認の増加と、この分野における継続的な研究開発活動が市場の成長に寄与しています。
  • 世界市場における新薬のイントロダクションと相まって、ヒトにおける成長ホルモン欠乏症の治療と早期診断に関する認知度が高いことから、成長ホルモン欠乏症の用途分野が2022年の市場を独占しました。
  • 最終用途に基づくと、成長ホルモン欠乏症とその治療効果に関する意識の高まりに牽引された通院回数の増加により、病院薬局分野が2022年の市場を独占しました。
  • 組換えDNA技術は、数多くの医薬品、特に成長ホルモン欠乏症に苦しむ大人と子供の両方における成長ホルモン補充治療に使用される医薬品の設計と製造において重要な役割を果たしています。
  • 同市場は、家庭用A1C検査分野で収益が増加し、2022年には第2位の検査分野となる見込みです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響分析

第4章 製品ビジネス分析

  • ヒト成長ホルモン市場：製品変動分析
  • 長時間作用型
    • 長期にわたる市場、2018～2030年
  • その他
    • その他市場、2018-2030

第5章 アプリケーションビジネス分析

  • ヒト成長ホルモン市場：アプリケーション変動分析
  • 成長ホルモン欠乏症
  • ターナー症候群
  • 特発性低身長
  • プラダーウィリ症候群
  • 在胎期間の割に小さい
  • その他

第6章 流通チャネルのビジネス分析

  • ヒト成長ホルモン市場：流通チャネルの変動分析
  • 病院薬局
    • 病院薬局市場、2018～2030年
  • 小売薬局
    • 小売薬局市場、2018～2030年
  • オンライン薬局
    • オンライン薬局市場、2018～2030年
  • 専門薬局
    • 専門薬局市場、2018年から2030年

第7章 地域ビジネス分析

  • ヒト成長ホルモン市場シェア、地域別、2022年および2030年
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業の市場シェア分析、2022年
  • 企業プロファイル・一覧表
    • Novo Nordisk A/S
    • Pfizer, Inc
    • Eli Lilly and Company
    • Sandoz International GmbH（Novartis AG）
    • Merck KGaA
    • Genentech, Inc（Roche）
    • Ferring Pharmaceuticals
    • Teva Pharmaceutical Industries, Ltd
    • Ipsen
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Human Growth Hormone Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 Global Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 6 Global Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 7 North America Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
  • Table 8 North America Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 9 North America Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 10 North America Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 11 U.S. Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 12 U.S. Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 14 Canada Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 Canada Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 16 Canada Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 17 Europe Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
  • Table 18 Europe Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 19 Europe Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Europe Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 21 UK Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 22 UK Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 UK Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24 Germany Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 25 Germany Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 26 Germany Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 27 France Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 28 France Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 29 France Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30 Italy Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Italy Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 32 Italy Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 33 Spain Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 34 Spain Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 35 Spain Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 36 Russia Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 37 Russia Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 38 Russia Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 39 Denmark Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 40 Denmark Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 41 Denmark Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42 Sweden Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 43 Sweden Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 44 Sweden Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 45 Norway Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 46 Norway Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 47 Norway Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 52 China Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 53 China Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 54 China Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 55 India Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 56 India Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 57 India Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58 South Korea Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 59 South Korea Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 60 South Korea Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 61 Japan Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 62 Japan Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 63 Japan Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 64 Singapore Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 65 Singapore Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 66 Singapore Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 67 Australia Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 68 Australia Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 69 Australia Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 70 Thailand Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 71 Thailand Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 72 Thailand Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 73 Latin America Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
  • Table 74 Latin America Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 75 Latin America Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 76 Latin America Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 77 Brazil Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 78 Brazil Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 79 Brazil Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 80 Mexico Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 81 Mexico Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 82 Mexico Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 83 Argentina Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 84 Argentina Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 85 Argentina Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 86 Middle East & Africa Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
  • Table 87 Middle East & Africa Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 88 Middle East & Africa Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 89 Middle East & Africa Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 90 South Africa Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 91 South Africa Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 92 South Africa Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 93 Saudi Arabia Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 95 Saudi Arabia Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 96 UAE Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 97 UAE Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 98 UAE Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 99 Kuwait Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 100 Kuwait Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 101 Kuwait Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Human Growth Hormone Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Human growth hormone market: Product outlook and key takeaways
  • Fig. 15 Human growth hormone market: Product movement analysis & market share 2022 & 2030
  • Fig. 16 Long-acting market, 2018 - 2030 (USD Million)
  • Fig. 17 Others market, 2018 - 2030 (USD Million)
  • Fig. 18 Human growth hormone market: Application outlook and key takeaways
  • Fig. 19 Human growth hormone market: Application movement analysis & market share 2022 & 2030
  • Fig. 20 Growth hormone deficiency market, 2018 - 2030 (USD Million)
  • Fig. 21 Adult growth hormone deficiency market, 2018 - 2030 (USD Million)
  • Fig. 22 Pediatric growth hormone deficiency market, 2018 - 2030 (USD Million)
  • Fig. 23 Turner syndrome market, 2018 - 2030 (USD Million)
  • Fig. 24 Idiopathic short stature market, 2018 - 2030 (USD Million)
  • Fig. 25 Prader-Willi syndrome market, 2018 - 2030 (USD Million)
  • Fig. 26 Small for gestational age market, 2018 - 2030 (USD Million)
  • Fig. 27 Other market, 2018 - 2030 (USD Million)
  • Fig. 28 Human growth hormone market: Distribution channel method outlook and key takeaways
  • Fig. 29 Human growth hormone market: Distribution channel method movement analysis & market share 2022 & 2030
  • Fig. 30 Hospital pharmacy market, 2018 - 2030 (USD Million)
  • Fig. 31 Retail pharmacy market, 2018 - 2030 (USD Million)
  • Fig. 32 Online pharmacy market, 2018 - 2030 (USD Million)
  • Fig. 33 Specialty pharmacy market, 2018 - 2030 (USD Million)
  • Fig. 34 Regional Marketplace: Key Takeaways
  • Fig. 35 Regional Outlook, 2022 & 2030
  • Fig. 36 Regional Market Dashboard
  • Fig. 37 Regional Market Place: Key Takeaways
  • Fig. 38 North America
  • Fig. 39 North America Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Key Country Dynamics
  • Fig. 41 U.S. America Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 42 Canada Key Country Dynamics
  • Fig. 43 Canada Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 44 Europe Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 45 UK Key Country Dynamics
  • Fig. 46 UK Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 47 Germany Key Country Dynamics
  • Fig. 48 Germany Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 49 France Key Country Dynamics
  • Fig. 50 France Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 51 Italy Key Country Dynamics
  • Fig. 52 Italy Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 53 Spain Key Country Dynamics
  • Fig. 54 Spain Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden Key Country Dynamics
  • Fig. 56 Sweden Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 57 Norway Key Country Dynamics
  • Fig. 58 Norway Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 59 Denmark Key Country Dynamics
  • Fig. 60 Denmark Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 61 Russia Key Country Dynamics
  • Fig. 62 Russia Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 63 Turkey Key Country Dynamics
  • Fig. 64 Turkey Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific America Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 66 Japan Key Country Dynamics
  • Fig. 67 Japan Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 68 China Key Country Dynamics
  • Fig. 69 China Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 70 India Key Country Dynamics
  • Fig. 71 India Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 72 Australia Key Country Dynamics
  • Fig. 73 Australia Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 74 Thailand Key Country Dynamics
  • Fig. 75 Thailand Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 76 South Korea Key Country Dynamics
  • Fig. 77 South Korea Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 78 Indonesia Key Country Dynamics
  • Fig. 79 Indonesia Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 80 Latin America Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 81 Brazil Key Country Dynamics
  • Fig. 82 Brazil Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 83 Mexico Key Country Dynamics
  • Fig. 84 Mexico Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 85 Argentina Key Country Dynamics
  • Fig. 86 Argentina Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 87 Middle East and Africa America Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 88 South Africa Key Country Dynamics
  • Fig. 89 South Africa Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 90 Saudi Arabia Key Country Dynamics
  • Fig. 91 Saudi Arabia Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 92 UAE Key Country Dynamics
  • Fig. 93 UAE Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 94 Kuwait Key Country Dynamics
  • Fig. 95 Kuwait Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 96 Nigeria Key Country Dynamics
  • Fig. 97 Nigeria Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 98 Strategy Mapping
目次
Product Code: GVR-2-68038-057-6

Human Growth Hormone Market Growth & Trends:

The global human growth hormone market size is expected to reach USD 14.28 billion by 2030, growing at a CAGR of 12.3% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The market is witnessing growth due to an increase in the incidence of growth hormone deficiency and other growth-related disorders. In addition, market growth is being driven by intense competition among key players striving to develop innovative and cost-effective treatment options. The increasing parental concerns regarding the growth of their children are contributing to the rising demand for human growth hormone (HGH) therapy. Reports from Canada Today highlight that parents are showing particular concern about the height of their children and are willing to invest in treatment options for dwarfism.

Similarly, in China, there is a high demand for HGH treatment for children, even in the absence of any medical abnormality. These growing concerns about the normal development of children have opened up new opportunities for industry players. North America is projected to experience rapid growth driven by increasing healthcare awareness among the population, significant government initiatives, and favorable reimbursement policies in the region. Furthermore, a rise in research & development activities, the availability of sufficient research funding, and the presence of organizations that actively promote awareness & treatment options are expected to drive the regional market growth.

In addition, the North America market benefits from the strong presence of top industry players, including Pfizer Inc. and Lilly, which significantly contributes to its profitable revenue share in the global industry. The increasing number of regulatory approvals and the introduction of innovative HGH treatment regimens are also contributing to the market expansion. For instance, in January 2022, Pfizer, Inc. and OPKO Health, Inc. obtained approval from the U.S. Food and Drug Administration (FDA) for NGENLA's commercialization, an advanced long-acting growth hormone injection with a once-a-week dosage for treating growth hormone deficiency in the country. NGENLA is anticipated to be available for prescription in the United States starting from August 2023.

Similarly, in August 2021, the U.S. FDA approved lonapegsomatropin-tcgd (SKYTROFA) introduced by Ascendis Pharma, for the treatment of development stoppage in pediatric patients. These regulatory approvals and the launch of novel HGH regimens are contributing to the market's expansion and driving further advancements in the field. North America held the largest revenue share in 2022 due to a rise in awareness among people about growth hormone deficiency and its treatments, along with an emphasis on early diagnosis. Asia Pacific is expected to exhibit the fastest CAGR over the forecast period due to the rising investments by leading players and the surge in generic adoption in the region.

India and China are anticipated to offer significant opportunities for the advancement of the healthcare sector, driven by their large population. Consequently, pharmaceutical companies, including those specializing in HGH drugs, are making substantial investments in these countries. Pfizer Inc., Novartis AG, Merck & Co., Inc., and Teva Pharmaceutical Industries Ltd. dominate the global market. These companies adopt strategies, such as new product development, merger & acquisition, and partnership, to increase their market share. In June 2023, the global health and fitness industry leader, Domestic Supply, launched a scientifically validated HGH supplement. This novel product marks a remarkable advancement in the field of performance enhancement and overall well-being, offering health-conscious individuals worldwide an enhanced quality of life

Human Growth Hormone Market Report Highlights:

  • Based on product, the others segment including the short-acting growth hormone dominated the market in 2022. Increased approvals by regulatory authorities for short-acting GH therapies, along with ongoing R&D activities in this field, contribute to the growth of the market
  • The growth hormone deficiency application segment dominated the market in 2022 due to the high awareness levels about the treatment of growth hormone deficiency and early diagnosis in humans, coupled with the introduction of new drugs in the global market
  • Based on the end-use, the hospital pharmacy segment dominated the market in 2022 due to the increased number of hospital visits driven by rising awareness about growth hormone deficiency and the effectiveness of its treatments
  • Recombinant DNA technology plays a crucial role in designing and manufacturing numerous drugs, particularly those used for growth hormone replacement treatment in both adults and children who suffer from growth hormone deficiency
  • The market is expected to witness increased revenue generation in the at-home A1C testing segment, positioning it as the second-largest testing segment in 2022, primarily driven by higher adoption rates

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Application segment
      • 1.1.1.2. Product segment
      • 1.1.1.3. Distribution channel segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Application and Product Snapshot
  • 2.3. Distribution Channel Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of human growth hormone
      • 3.2.1.2. Growing investments and governmental funding in the development of diagnostics
      • 3.2.1.3. Growing awareness of human growth hormone
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Shift of funds to tackle other diseases in low health budgets.
      • 3.2.2.2. Shortage of funding from international partners and foreign government
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Human Growth Hormone Market: Product Movement Analysis
  • 4.2. Long Acting
    • 4.2.1. Long Acting Market, 2018 - 2030 (USD Million)
  • 4.3. Others
    • 4.3.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Human Growth Hormone Market: Application Movement Analysis
  • 5.2. Growth Hormone Deficiency
    • 5.2.1. Growth Hormone Deficiency Market, 2018 - 2030 (USD Million)
    • 5.2.2. Adult Growth Hormone Deficiency
      • 5.2.2.1. Adult Growth Hormone Deficiency Market, 2018 - 2030 (USD Million)
    • 5.2.3. Pediatric Growth Hormone Deficiency
      • 5.2.3.1. Pediatric Growth Hormone Deficiency Market, 2018 - 2030 (USD Million)
  • 5.3. Turner Syndrome
    • 5.3.1. Turner Syndrome Market, 2018 - 2030 (USD Million)
  • 5.4. Idiopathic Short Stature
    • 5.4.1. Idiopathic Short Stature Market, 2018 - 2030 (USD Million)
  • 5.5. Prader-Willi Syndrome
    • 5.5.1. Prader-Willi Syndrome Market, 2018 - 2030 (USD Million)
  • 5.6. Small for Gestational Age
    • 5.6.1. Small for Gestational Age Market, 2018 - 2030 (USD Million)
  • 5.7. Other
    • 5.7.1. Other Market, 2018 - 2030 (USD Million)

Chapter 6. Distribution Channel Business Analysis

  • 6.1. Human Growth Hormone Market: Distribution Channel Movement Analysis
  • 6.2. Hospital Pharmacy
    • 6.2.1. Hospital Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.3. Retail Pharmacy
    • 6.3.1. Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.4. Online Pharmacy
    • 6.4.1. Online Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.5. Specialty Pharmacy
    • 6.5.1. Specialty Pharmacy Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Human Growth Hormone Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. U.S. Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Competitive Scenario
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Canada Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. UK Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.4. Germany
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Germany Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. France Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Italy Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Spain Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Sweden Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Norway Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.10. Denmark
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Competitive Scenario
      • 7.3.10.3. Regulatory Framework
      • 7.3.10.4. Denmark Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.11. Russia
      • 7.3.11.1. Key Country Dynamics
      • 7.3.11.2. Competitive Scenario
      • 7.3.11.3. Regulatory Framework
      • 7.3.11.4. Russia Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Japan Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. China Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. India Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Australia Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Thailand Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.8. South Korea
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. South Korea Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.9. Singapore
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Indonesia Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Brazil Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Mexico Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Argentina Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
    • 7.6.2. MEA Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. South Africa Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Saudi Arabia Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.6.5. UAE
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. UAE Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.6.6. Kuwait
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Kuwait Human Growth Hormone Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Novo Nordisk A/S
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Pfizer, Inc
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Eli Lilly and Company
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Sandoz International GmbH (Novartis AG)
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Merck KGaA
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Genentech, Inc (Roche)
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Ferring Pharmaceuticals
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Teva Pharmaceutical Industries, Ltd
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Ipsen
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives